Home Industry Reports Custom Research Blogs About Us Contact us

Sustained Release Excipients Market Share

Report ID: FBI 1454

|

Published Date: Sep-2023

|

Format : PDF, Excel

Segmentation Analysis:

The sustained release excipients market can be segmented based on type, formulation, and application. One notable sub-segment from each segment is discussed below.

Segment: Type

Sub-segment: Polymers

Polymers are a commonly used type of sustained release excipient. They offer various advantages, including controlled drug release, improved bioavailability, enhanced stability, and customized drug release rates. Polymers such as hydrogels, biodegradable polymers, and pH-sensitive polymers enable precise control and sustained release of drugs over an extended period. Furthermore, the increasing demand for biodegradable polymers in sustained release formulations promotes the growth of the polymer sub-segment within the sustained release excipients market.

Segment: Formulation

Sub-segment: Injectable

The injectable formulation sub-segment is gaining significant traction in the sustained release excipients market. Injectable sustained release formulations offer numerous advantages, such as sustained drug release, reduced dosing frequency, and improved patient compliance. They are widely utilized for the delivery of peptides, proteins, and other therapeutic agents. The growing demand for long-acting injectable formulations, especially for chronic diseases, fuels the adoption of injectable sustained release excipients, driving the growth of this sub-segment.

Segment: Application

Sub-segment: Cardiovascular Diseases

Sustained release excipients find extensive application in the treatment of cardiovascular diseases. By providing controlled drug release, sustained release excipients help in maintaining optimal drug concentrations in the bloodstream, thereby enhancing treatment efficacy and reducing the frequency of administration. These excipients are utilized in the formulation of sustained release drugs for conditions such as hypertension, angina, and heart failure. The increasing prevalence of cardiovascular diseases globally drives the demand for sustained release excipients in this application segment.

Get more details on this report -

Competitive Landscape:

The sustained release excipients market is highly competitive, with several prominent players operating worldwide. Some of the key market players include:

1. DowDuPont Inc.

2. Ashland Global Holdings Inc.

3. Evonik Industries AG

4. BASF SE

5. Colorcon Inc.

6. Lubrizol Corporation

7. FMC Corporation

8. Roquette Freres

9. Shin-Etsu Chemical Co., Ltd.

10. Croda International Plc.

These companies focus on strategic partnerships, mergers and acquisitions, and product launches to strengthen their market position. Additionally, research and development activities aimed at developing innovative sustained release excipients are undertaken to gain a competitive edge. The sustained release excipients market is characterized by intense competition and technological advancements, driving the market players to constantly innovate and expand their product portfolios.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Sustained Release Excipients Market Size & Share, ...

RD Code : 24